
Is PacBio Cursed?
A reader commented after my recent post that PacBio seems to be cursed.
ASeq is Nava Whiteford’s newsletter on DNA sequencing, protein sequencing, diagnostics, life-science tools, biotech company strategy, COGS. And all sorts of other biotech related fun!
Live Last read · last published · next check

A reader commented after my recent post that PacBio seems to be cursed.

The public version of the Biobase is now at >32000 companies.

Oxford have released their interim H1 results. Highlights include:

You see these things a lot, these neat devices which let phlebotomist find veins and draw blood more easily.

ex-Illumina CEO Jay Flatley is now CEO of Radian according to rumors I’ve heard from a number of sources and confirmed by this SEC filing.

I’ve been hearing rumors that DNA electronics is dead for a while, but this is the first public post I’ve seen.

Acorn are a solid state nanopore sequencing company, who current appear to be shipping qPCR machines.

There was some chat about Bosch on the Discord today after someone posted a job opening for Bosch molecular diagnostics.

I was poking around in the Biobase and came across DirectSeq, a direct RNA sequencing company.

Mike has posted a teardown of the MinION and flowcell over on Youtube.

I’ve been working on a few new ways of visualizing patent portfolios.

The public Biobase now has 31000 companies. I believe this is now a somewhat comprehensive database of all Biotech companies.

Alamar Biosciences have a protein readout system based on oligo labelled antibodies.

PacBio has a new CEO and his name is Mark Van Oene.

Yesterday I looked at VividDx, a Raman based single cell diagnostics company.

VividDx is building a single cell Raman diagnostics platform.

For your consideration:

Based on their report at JPM in January I speculated that the clinical growth they are seeing will continue to see Illumina grow, despite a decline in research revenue.

“Do not go gentle into that good night.

The company recently announced Q2 results, with essentially no revenue. And GenomeWeb is reporting that their “broadscale” platform is delayed.

I don’t understand what Quantum Diamond Technologies is… hopefully I will by the end of this post.

I recently came across Ignite Proteomics. The name is weirdly familiar, the somewhat troubled proteomics company Nautilus Biosciences was first incorporated as Ignite Biosciences.

Cepheid have announced a next generation GeneXpert. GeneXpert is a sample-to-answer qPCR platform. You can take a swab, stick it in a cartridge and within an hour generate a report. They have for example a Flu-RSV-COVID cartridge which will tell you if you have COVID or something else.